7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Congenital Heart Diseases
The complexity of congenital heart diseases lies in the wide range of defects affecting the heart’s anatomy and blood flow. Some conditions, such as patent ductus arteriosus, may resolve spontaneously, while others demand intricate surgical repairs or catheter-based interventions. The integration of 3D imaging and artificial intelligence has significantly improved the precision of preoperative planning and patient-specific therapies. Beyond childhood, ongoing research highlights the importance of lifelong monitoring and care to address potential complications in adulthood. This field not only advances medical treatments but also fosters multidisciplinary approaches that prioritize patient-centered care for individuals with congenital heart diseases.
Yochai Birnbaum
Baylor College of Medicine, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States
Narendra Kumar
HeartbeatsZ Academy, United KingdomSubmit your abstract Today
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom